Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug repurposing screening and mechanism analysis based on human colorectal cancer organoids
Yunuo Mao, Wei Wang, Jingwei Yang, et al.
Protein & Cell (2023) Vol. 15, Iss. 4, pp. 285-304
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine
Shanqiang Qu, Rongyang Xu, Guozhong Yi, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 16
Spatial Transcriptomics: A Powerful Tool in Disease Understanding and Drug Discovery
Junxian Cao, Caifeng Li, Zhao Cui, et al.
Theranostics (2024) Vol. 14, Iss. 7, pp. 2946-2968
Open Access | Times Cited: 15
Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response
Lidwien P. Smabers, Emerens Wensink, Carla S. Veríssimo, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 10
Hyaluronic acid-conjugated methotrexate and 5-fluorouracil for targeted drug delivery
Wanfei Shao, Yanfang Yang, Weidong Shen, et al.
International Journal of Biological Macromolecules (2024) Vol. 273, pp. 132671-132671
Closed Access | Times Cited: 9
Current applications of intestinal organoids: a review
Tao Xiang, Jie Wang, Hui Li
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
From Organ-on-a-Chip to Human-on-a-Chip: A Review of Research Progress and Latest Applications
Yisha Huang, Tong Liu, Qi Huang, et al.
ACS Sensors (2024) Vol. 9, Iss. 7, pp. 3466-3488
Closed Access | Times Cited: 8
Unveiling Epigenetic Vulnerabilities in Triple-Negative Breast Cancer through 3D Organoid Drug Screening
Xinxin Rao, Zhibin Qiao, Yang Yang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 225-225
Open Access | Times Cited: 6
Signaling pathways in colorectal cancer implications for the target therapies
Yanlin Song, Ming Chen, Yuhao Wei, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 6
Current trends and future prospects of drug repositioning in gastrointestinal oncology
Nayeralsadat Fatemi, Mina Karimpour, Hoda Bahrami, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 5
Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine
Qigu Yao, Sheng Cheng, Qiaoling Pan, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 5
A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine
Jessica Kalla, Janette Pfneissl, Theresia Mair, et al.
Cellular Oncology (2024)
Open Access | Times Cited: 4
Organoid-Based Assessment of Metal–Organic Framework (MOF) Nanomedicines for Ex Vivo Cancer Therapy
Dan Li, Rui Zhang, Yinpeng Le, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 26, pp. 33070-33080
Closed Access | Times Cited: 4
Epidermal Growth Factor Receptor Targeting in Colorectal Carcinoma: Antibodies and Patient-Derived Organoids as a Smart Model to Study Therapy Resistance
Samuele Tardito, Serena Matis, Maria Raffaella Zocchi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7131-7131
Open Access | Times Cited: 4
Targeting SLC4A4: A Novel Approach in Colorectal Cancer Drug Repurposing
Krunal Pawar, Pramodkumar P. Gupta, Pooran Singh Solanki, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 1, pp. 67-67
Open Access
Strategies for Redesigning Withdrawn Drugs to Enhance Therapeutic Efficacy and Safety: A Review
Chirag Patel, Adeeba Shakeel, Raghvendra Mall, et al.
Wiley Interdisciplinary Reviews Computational Molecular Science (2025) Vol. 15, Iss. 1
Closed Access
An update on drug repurposing in Parkinson’s disease: Preclinical and clinical considerations
Michela Salvadè, Mónica Di Luca, Fabrizio Gardoni
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117862-117862
Closed Access
Prognostic models of immune-related cell death and stress unveil mechanisms driving macrophage phenotypic evolution in colorectal cancer
Hao Liu, Chuhan Zhang, Sanfei Peng, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Tumor organoids in cancer medicine: from model systems to natural compound screening
Rong Cong, Can Lu, Xinying Li, et al.
Pharmaceutical Biology (2025) Vol. 63, Iss. 1, pp. 89-109
Open Access
Identification and functional characterization of m1A-related genes in colorectal cancer: implications for prognosis, immune infiltration, and therapeutic strategies
Lan Sun, Longtao Huangfu, Li Fang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Opportunities of patient‐derived organoids in drug development
Antonia Büning, Elena S. Reckzeh
British Journal of Pharmacology (2025)
Open Access
Beyond digital twins: the role of foundation models in enhancing the interpretability of multiomics modalities in precision medicine
Sakhaa B. Alsaedi, Xin Gao, Takashi Gojobori
FEBS Open Bio (2025)
Open Access
Assessing the Therapeutic Value of Primary Tumor Resection in Colorectal Cancer Lung Metastases: A Dynamic Visualization Clinical Tool Constructed Based on the SEER Database
Jinyi Xu, Xiaoqiang Niu
Journal of Gastroenterology and Hepatology (2025)
Closed Access
Colorectal Organoids: Models, Imaging, Omics, Therapy, Immunology, and Ethics
Martina Taglieri, Linda Di Gregorio, Serena Matis, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 457-457
Open Access
Evaluation of FOXF1 promoter DNA methylation, as a promising epigenetic biomarker for colorectal cancer in stool samples
Susan Tahmasebi, Bayan Mehrjoei, Asad Vaisi‐Raygani, et al.
(2025)
Closed Access
A growth factor-reduced culture system for colorectal cancer organoids
Ronghui Tan, Ze Zhang, Peirong Ding, et al.
Cancer Letters (2024) Vol. 588, pp. 216737-216737
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top